Healthequity Inc (HQY +$3.25 or +4.20% to $80.63) found support while recently sputtering near its 200-day moving average (DMA) line ($77.22) after damaging losses violated the prior low ($80.56 on 10/24/18) triggering a technical sell signal. A subsequent rebound above the 50 DMA line ($88.62) is needed for its outlook to improve. It now faces resistance due to overhead supply up to the $99 level.

HQY was last shown in this FSU section on 11/01/18 with an annotated graph under the headline, "Rebound Above 50-Day Average Helped Outlook Improve". It reported earnings +62% on +25% sales revenues for the Jul '18 quarter versus the year ago period, continuing its strong earnings track record. Fundamentals remain strong, as the past 7 quarterly comparisons were above the +25% minimum earnings guideline (C criteria) and underpinned by strong sales revenues increases.

It has managed a bumpy climb that may have shaken out many investors since triggering a technical buy signal with a gain above the new pivot point with +90% above average volume when highlighted in the 2/20/18 mid-day report (read here).

The number of top-rated funds owning its shares rose from 369 in Dec '16 to 547 in Sep '18, a reassuring sign concerning the I criteria. Its current Up/Down Volume Ratio of 1.4 is also an unbiased indication its shares have been under accumulation over the past 50 days. It has a fairly small supply of only 62.3 million shares (S criteria) outstanding, which can contribute to greater price volatility in the event of institutional buying or selling. It currently has a Timeliness Rating of B and a Sponsorship Rating of B.

The Commercial Services - Outsourcing industry group currently has a Group Relative Strength Rating of 49, however there are other strong leaders in the group, a reassuring sign concerning the L criteria. It completed its $14 IPO on 7/31/14 followed by an additional Public Offering on 5/05/15 and Secondary Offerings on both 10/20/16 and 9/23/15.

Charts used courtesy of www.stockcharts.com

Healthequity Inc (HQY +$2.82 or +3.07% to $94.62) gapped up on the prior session and posted another big gain today with above average volume, rebounding above the 50-day moving average (DMA) line ($90.55) and helping its outlook to improve. It faces some resistance due to overhead supply up to the $99 level. It found support near prior highs in the $82-83 area, but more damaging losses would raise serious concerns.

HQY was last shown in this FSU section on 10/16/18 with an annotated graph under the headline, "Below 50-Day Moving Average Which May Act as Resistance". It reported earnings +62% on +25% sales revenues for the Jul '18 quarter versus the year ago period, continuing its strong earnings track record. Fundamentals remain strong, as the past 7 quarterly comparisons were above the +25% minimum earnings guideline (C criteria) and underpinned by strong sales revenues increases.

The number of top-rated funds owning its shares rose from 369 in Dec '16 to 528 in Sep '18, a reassuring sign concerning the I criteria. Its current Up/Down Volume Ratio of 1.8 is also an unbiased indication its shares have been under accumulation over the past 50 days. It has a fairly small supply of only 62.3 million shares (S criteria) outstanding, which can contribute to greater price volatility in the event of institutional buying or selling. It currently has a Timeliness Rating of A and a Sponsorship Rating of B.

The Commercial Services - Outsourcing industry group currently has a Group Relative Strength Rating of 63, however there are other strong leaders in the group hitting new highs, a reassuring sign concerning the L criteria. It completed its $14 IPO on 7/31/14 followed by an additional Public Offering on 5/05/15 and Secondary Offerings on both 10/20/16 and 9/23/15.

Charts used courtesy of www.stockcharts.com

Healthequity Inc (HQY +$3.82 or +4.62% to $86.45) posted a big gain today rebounding toward its 50 DMA line ($89.95). That important short-term average may act as resistance. It found support near prior highs in the $82-83 area, but more damaging losses would raise serious concerns.

It was last shown in this FSU section on 9/10/18 with an annotated graph under the headline, "Very Extended From Any Sound Base After Streak of Gains". It reported earnings +62% on +25% sales revenues for the Jul '18 quarter versus the year ago period, continuing its strong earnings track record. Fundamentals remain strong, as the past 7 quarterly comparisons were above the +25% minimum earnings guideline (C criteria) and underpinned by strong sales revenues increases.

The number of top-rated funds owning its shares rose from 369 in Dec '16 to 511 in Jun '18, a reassuring sign concerning the I criteria. Its current Up/Down Volume Ratio of 2.1 is also an unbiased indication its shares have been under accumulation over the past 50 days. It has a fairly small supply of only 62.3 million shares (S criteria) outstanding, which can contribute to greater price volatility in the event of institutional buying or selling. It currently has a Timeliness Rating of A and a Sponsorship Rating of B.

The Commercial Services - Outsourcing industry group currently has a Group Relative Strength Rating of 70, however there are other strong leaders in the group hitting new highs, a reassuring sign concerning the L criteria. It completed its $14 IPO on 7/31/14 followed by an additional Public Offering on 5/05/15 and Secondary Offerings on both 10/20/16 and 9/23/15.

Charts used courtesy of www.stockcharts.com

Healthequity Inc (HQY -$0.48 or -0.49% to $96.59) is perched near its all-time high following impressive volume-driven gains. It is very extended from any sound base. Prior highs in the $82-83 area define support along with its 50 DMA line ($83.86). It was last shown in this FSU section on 7/25/18 with an annotated graph under the headline, "Perched Near All-Time High After Testing Support at 50-Day Average".

It reported earnings +62% on +25% sales revenues for the Jul '18 quarter versus the year ago period, continuing its strong earnings track record. Fundamentals remain strong, as the past 7 quarterly comparisons were above the +25% minimum earnings guideline (C criteria) and underpinned by strong sales revenues increases.

The number of top-rated funds owning its shares rose from 369 in Dec '16 to 485 in Jun '18, a reassuring sign concerning the I criteria. Its current Up/Down Volume Ratio of 3.0 is also an unbiased indication its shares have been under accumulation over the past 50 days. It has a fairly small supply of only 62 million shares (S criteria) outstanding, which can contribute to greater price volatility in the event of institutional buying or selling. It currently has a Timeliness Rating of A and a Sponsorship Rating of B.

The Commercial Services - Outsourcing industry group currently has a Group Relative Strength Rating of 83, and there are other strong leaders in the group hitting new highs, a reassuring sign concerning the L criteria. It completed its $14 IPO on 7/31/14 followed by an additional Public Offering on 5/05/15 and Secondary Offerings on both 10/20/16 and 9/23/15.

Charts used courtesy ofwww.stockcharts.com

Healthequity Inc (HQY +$2.43 or +3.04% to $82.28) posted a big gain today with light volume as it rebounded near its all-time high. It found encouraging support while recently consolidating above its 50-day moving average (DMA) line ($78.24), but it did not form a base pattern of sufficient length.

HQY was last shown in this FSU section on 6/07/18 with an annotated graph under the headline, "Pullback After Volume-Driven Gains For New Highs". It reported earnings +63% on +26% sales revenues for the Apr '18 quarter versus the year ago period, continuing its strong earnings track record. Fundamentals remain strong, as the past 6 quarterly comparisons were above the +25% minimum earnings guideline (C criteria) and underpinned by strong sales revenues increases.

Members were previously reminded - "Disciplined investors always limit losses by selling any stock that falls more than -7% from their purchase price, knowing they can always buy back any stock if strength returns." It has managed a bumpy climb that may have shaken out many investors since triggering a technical buy signal with a gain above the new pivot point with +90% above average volume when highlighted in the 2/20/18 mid-day report (read here).

The number of top-rated funds owning its shares rose from 369 in Dec '16 to 462 in Jun '18, a reassuring sign concerning the I criteria. Its current Up/Down Volume Ratio of 2.1 is also an unbiased indication its shares have been under accumulation over the past 50 days. It has a fairly small supply of only 62 million shares (S criteria) outstanding, which can contribute to greater price volatility in the event of institutional buying or selling. It currently has a Timeliness Rating of A and a Sponsorship Rating of B.

Charts used courtesy ofwww.stockcharts.com

Healthequity Inc (HQY -$3.59 or -4.46% to $76.82) pulled back today following volume-driven gains for new all-time highs. It is very extended from any sound base. The prior high ($68.75 on 3/22/18) and its 50-day moving average (DMA) line ($69.06) define near term support to watch on pullbacks.

HQY was last shown in this FSU section on 4/25/18 with an annotated graph under the headline, " Perched Near All-Time High Building a Short New Base". It reported earnings +57% on +29% sales revenues for the Jan '18 quarter versus the year ago period, continuing its strong earnings track record. HQY's fundamentals remain strong, as the past 5 quarterly comparisons were above the +25% minimum earnings guideline (C criteria) and underpinned by strong sales revenues increases.

Members were previously reminded - "Disciplined investors always limit losses by selling any stock that falls more than -7% from their purchase price, knowing they can always buy back any stock if strength returns."It has managed a bumpy climb that may have shaken out many investors since triggering a technical buy signal with a gain above the new pivot point with +90% above average volume when highlighted in the 2/20/18 mid-day report (read here).

The number of top-rated funds owning its shares rose from 369 in Dec '16 to 438 in Mar '18, a reassuring sign concerning the I criteria. Its current Up/Down Volume Ratio of 2.5 is also an unbiased indication its shares have been under accumulation over the past 50 days. It has a fairly small supply of only 61.8 million shares (S criteria) outstanding, which can contribute to greater price volatility in the event of institutional buying or selling. It currently has a Timeliness Rating of A and a Sponsorship Rating of B.

The Commercial Services - Outsourcing industry group currently has a Group Relative Strength Rating of 79, and there are other strong leaders in the group hitting new highs, a reassuring sign concerning the L criteria. It completed its $14 IPO on 7/31/14 followed by an additional Public Offering on 5/05/15 and Secondary Offerings on both 10/20/16 and 9/23/15.

Charts used courtesy ofwww.stockcharts.com

Healthequity Inc (HQY +$0.45 or +0.69% to $65.56) has been hovering near its all-time high, and volume totals have cooled while building a short new base. Its 50-day moving average (DMA) line ($60.41) defines near term support above prior highs. HQY was last shown in this FSU section on 3/22/18 with an annotated graph under the headline, "Bullish Action Followed Latest Earnings Report".

It reported earnings +57% on +29% sales revenues for the Jan '18 quarter versus the year ago period, continuing its strong earnings track record. HQY's fundamentals remain strong, as the past 4 quarterly comparisons were above the +25% minimum earnings guideline (C criteria) and underpinned by strong sales revenues increases.

The number of top-rated funds owning its shares rose from 369 in Dec '16 to 421 in Mar '18, a reassuring sign concerning the I criteria. Its current Up/Down Volume Ratio of 2.9 is also an unbiased indication its shares have been under accumulation over the past 50 days. It has a fairly small supply of only 61 million shares (S criteria) outstanding, which can contribute to greater price volatility in the event of institutional buying or selling. It currently has a Timeliness Rating of A and a Sponsorship Rating of B.

Charts used courtesy of www.stockcharts.com

Healthequity Inc (HQY +$1.36 or +2.08% to $66.82) tallied a 3rd consecutive volume-driven gain hitting new all-time highs, getting very extended from any sound base. Prior highs in the $55 area define initial support along with its 50-day moving average (DMA) line.

Bullish action came after it reported earnings +57% on +29% sales revenues for the Jan '18 quarter versus the year ago period, continuing its strong earnings track record. HQY's fundamentals remain strong, as the past 4 quarterly comparisons were above the +25% minimum earnings guideline (C criteria) and underpinned by strong sales revenues increases.

Members were previously reminded - "Disciplined investors always limit losses by selling any stock that falls more than -7% from their purchase price, knowing they can always buy back any stock if strength returns." HQY was last shown in this FSU section on 2/21/18 with an annotated graph under the headline, "Fundamentals Remained Favorable and Strength Returned", as it hit a new high with a 9th consecutive gain. It triggered a technical buy signal with a gain above the new pivot point cited backed by +90% above average volume on the prior session when highlighted in the 2/20/18 mid-day report (read here).

The number of top-rated funds owning its shares rose from 369 in Dec '16 to 436 in Dec '17, a reassuring sign concerning the I criteria. Its current Up/Down Volume Ratio of 2.6 is also an unbiased indication its shares have been under accumulation over the past 50 days. It has a fairly small supply of only 60.7 million shares (S criteria) outstanding, which can contribute to greater price volatility in the event of institutional buying or selling. It currently has a Timeliness Rating of A and a Sponsorship Rating of C.

The Commercial Services - Outsourcing industry group currently has a Group Relative Strength Rating of 71, however there are other strong leaders in the group hitting new highs, a reassuring sign concerning the L criteria. It completed its $14 IPO on 7/31/14 followed by an additional Public Offering on 5/05/15 and Secondary Offerings on both 10/20/16 and 9/23/15.

Charts used courtesy of www.stockcharts.com

Healthequity Inc (HQY +$0.79 or +1.41% to $56.71) hit yet another new high with today's 9th consecutive gain. It triggered a technical buy signal with a gain above the new pivot point cited backed by +90% above average volume on the prior session when highlighted in the 2/20/18 mid-day report (read here). Disciplined investors always limit losses by selling any stock that falls more than -7% from their purchase price, knowing they can always buy back any stock if strength returns.

HQY's fundamentals remain strong, with earnings +70% on +31% sales revenues for the Oct '17 quarter. so the past 3 quarterly comparisons were above the +25% minimum earnings guideline (C criteria) and underpinned by strong sales revenues increases.

The number of top-rated funds owning its shares rose from 369 in Dec '16 to 441 in Dec '17, a reassuring sign concerning the I criteria. Its current Up/Down Volume Ratio of 2.5 is also an unbiased indication its shares have been under slight accumulation over the past 50 days. It has a fairly small supply of only 60.7 million shares (S criteria) outstanding, which can contribute to greater price volatility in the event of institutional buying or selling. It currently has a Timeliness Rating of A and a Sponsorship Rating of C.

The Commercial Services - Outsourcing industry group currently has a Group Relative Strength Rating of 52, however there are other strong leaders in the group hitting new highs, a reassuring sign concerning the L criteria. It completed its $14 IPO on 7/31/14 followed by an additional Public Offering on 5/05/15 and Secondary Offerings on both 10/20/16 and 9/23/15.

Charts used courtesy of www.stockcharts.com

Healthequity Inc (HQY -$2.60 or -5.05% to $48.86) slumped below its 50-day moving average (DMA) line ($50.47) with today's big loss on higher volume. An abrupt retreat back into the prior base raised concerns after a recent breakout. Disciplined investors always limit losses by selling any stock that falls more than -7% from their purchase price.

HQY was shown in this FSU section on 11/06/17 with an annotated graph under the headline, "Hit New High With Big Volume-Driven Gain". It was highlighted in yellow with new pivot point cited based on its 10/04/17 high in the 11/06/17 mid-day report (read here). It hit a new high with a considerable volume-driven gain triggering a technical buy signal.

Fundamentals remain strong as three of the past 4 quarterly comparisons through Jul '17 were above the +25% minimum earnings guideline (C criteria) and underpinned by strong sales revenues increases.

The number of top-rated funds owning its shares rose from 369 in Dec '16 to 442 in Sep '17, a reassuring sign concerning the I criteria. Its current Up/Down Volume Ratio of 1.2 is also an unbiased indication its shares have been under slight accumulation over the past 50 days. It has a fairly small supply of only 48.6 million shares (S criteria) outstanding, which can contribute to greater price volatility in the event of institutional buying or selling. It currently has a Timeliness Rating of B and a Sponsorship Rating of B.

The Commercial Services - Outsourcing industry group currently has a Group Relative Strength Rating of 69, however there are other strong leaders in the group hitting new highs, a reassuring sign concerning the L criteria. It completed its $14 IPO on 7/31/14 followed by an additional Public Offering on 5/05/15 and Secondary Offerings on both 10/20/16 and 9/23/15.

Charts used courtesy of www.stockcharts.com

Healthequity Inc (HQY +$3.15 or +6.20% to $53.96) was highlighted in yellow with new pivot point cited based on its 10/04/17 high in the earlier mid-day report (read here). It hit a new high with today's considerable volume-driven gain triggering a technical buy signal, and it faces no resistance due to overhead supply. Fundamentals remain strong as three of the past 4 quarterly comparisons through Jul '17 were above the +25% minimum earnings guideline (C criteria) and underpinned by strong sales revenues increases.

It tested and found support after rebounding above its 50-day moving average (DMA) line ($48.27) since last noted and dropped from the Featured Stocks list on 8/17/17. HQY was shown in this FSU section on 7/19/17 with an annotated graph under the headline, "50-Day Moving Average Violation Triggers Technical Sell Signal".

The number of top-rated funds owning its shares rose from 369 in Dec '16 to 426 in Sep '17, a reassuring sign concerning the I criteria. Its current Up/Down Volume Ratio of 1.5 is also an unbiased indication its shares have been under accumulation over the past 50 days. It has a fairly small supply of only 48.6 million shares (S criteria) outstanding, which can contribute to greater price volatility in the event of institutional buying or selling. It currently has a Timeliness Rating of B and a Sponsorship Rating of C.

The Commercial Services - Outsourcing industry group currently has a Group Relative Strength Rating of 73, however there are other strong leaders in the group hitting new highs, a reassuring sign concerning the L criteria. It completed its $14 IPO on 7/31/14 followed by an additional Public Offering on 5/05/15 and Secondary Offerings on both 10/20/16 and 9/23/15.

Charts used courtesy of www.stockcharts.com

Healthequity Inc (HQY -$0.79 or -1.61% to $48.30) undercut prior highs in the $49 area and violated its 50-day moving average (DMA) line ($48.82) trigger technical sell signals with a loss on higher volume indicative of distributional pressure. Only a prompt rebound above the 50 DMA line would help its outlook improve.

HQY was last shown in this FSU section on 6/07/17 with an annotated graph under the headline, "High Volume Breakout Quickly Getting Extended". It was highlighted with a pivot point cited based on its 1/24/17 high plus 10 cents in the 6/07/17 mid-day report (read here). It reported earnings +27% on +26% sales revenues for the Apr '17 quarter, and 3 of the past 4 quarterly comparisons had earnings increases above the +25% minimum guideline (C criteria). It completed yet another Secondary Offering on 10/20/16. Completed its $14 IPO on 7/31/14 followed by an additional Public Offering on 5/05/15 and a Secondary Offering on 9/23/15.

The number of top-rated funds owning its shares rose from 337 in Sep '16 to 404 in Jun '17, a reassuring sign concerning the I criteria. Its current Up/Down Volume Ratio of 1.6 is also an unbiased indication its shares have been under accumulation over the past 50 days. It has a fairly small supply of only 48.6 million shares (S criteria) outstanding, which can contribute to greater price volatility in the event of institutional buying or selling. It currently has a Timeliness Rating of B and a Sponsorship Rating of B. The Commercial Services - Outsourcing industry group currently has a mediocre Group Relative Strength Rating of 58, however there are other strong leaders in the group hitting new highs, a reassuring sign concerning the L criteria.

Charts used courtesy of www.stockcharts.com

Healthequity Inc (HQY +$4.19 or +8.64% to $52.68) finished strong after highlighted in yellow with a pivot point cited based on its 1/24/17 high plus 10 cents in the earlier mid-day report (read here). It hit a new high with today's 6th consecutive gain on ever-increasing volume. The strong close above the pivot point clinched a technical buy signal, however it is quickly getting extended from the proper buy range.

HQY found support recently at its 50-day moving average (DMA) line ($44.68). Reported earnings +27% on +26% sales revenues for the Apr '17 quarter, and 3 of the past 4 quarterly comparisons had earnings increases above the +25% minimum guideline (C criteria). Completed yet another Secondary Offering on 10/20/16. Completed its $14 IPO on 7/31/14 followed by an additional Public Offering on 5/05/15 and a Secondary Offering on 9/23/15.

The number of top-rated funds owning its shares has been on the rise, a reassuring sign concerning the I criteria. It has a fairly small supply of only 48.95 million shares (S criteria) outstanding, which can contribute to greater price volatility in the event of institutional buying or selling.

Charts used courtesy of www.stockcharts.com

Found Support at 200-Day Average But Faces Overhead Supply - Monday, November 26, 2018

Rebound Above 50-Day Average Helped Outlook Improve - Thursday, November 1, 2018

Below 50-Day Moving Average Which May Act as Resistance - Tuesday, October 16, 2018

Very Extended From Any Sound Base After Streak of Gains - Monday, September 10, 2018

Perched Near All-Time High After Testing Support at 50-Day Average - Wednesday, July 25, 2018

Pullback After Volume-Driven Gains For New Highs - Thursday, June 7, 2018

Perched Near All-Time High Building a Short New Base - Wednesday, April 25, 2018

Bullish Action Followed Latest Earnings Report - Thursday, March 22, 2018

Fundamentals Remained Favorable and Strength Returned - Wednesday, February 21, 2018

Sank Below 50-Day Moving Average With Loss on Higher Volume - Monday, December 4, 2017

Hit New High With Big Volume-Driven Gain - Monday, November 6, 2017

50-Day Moving Average Violation Triggers Technical Sell Signal - Wednesday, July 19, 2017

High Volume Breakout Quickly Getting Extended - Wednesday, June 7, 2017